FDA Approved: KISUNLA — Original Application (Eli Lilly and Company)

View source ↗

Summary

FDA approved Kisunla (donanemab-azbt) from Eli Lilly in an original Biologics License Application for adults with early Alzheimer's disease to slow cognitive de…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Kisunla (DONANEMAB-AZBT)

Snippet

ORIG AP for KISUNLA (DONANEMAB-AZBT)